Background
==========

Within the UK National Health Service (NHS), services which typically act as the first point of contact with the health care system are referred to as "primary care" and include general practitioners (GPs), dentists, pharmacists and optometrists. Within the NHS, the GP also plays the role of gatekeeper, managing referral to most non-emergency secondary (hospital and community) and tertiary (highly specialized) health care services. As a result, the majority of the UK population are registered with a GP and the GP record is the patient's primary medical record.[@b1-clep-10-1155] In line with this, guidelines indicate that the details of secondary care encounters should be routinely communicated to an individual's GP practice in order to allow for these details to be recorded and ensure continuity of care.[@b2-clep-10-1155] Databases containing data collected in UK primary care have therefore been widely used as a stand-alone resource for research into medical conditions and the drugs used to treat them.[@b3-clep-10-1155]

More recently, the linkage of English secondary and primary care datasets has facilitated the conduct of studies exploring the extent to which secondary care events are coded in primary care records. A number of these studies have found coding to be suboptimal, with 17% of cancers, 34% of GI bleeds, 21% of myocardial infarctions, 22% of poisoning events and 9% of fractures recorded in the linked dataset not appearing in the primary care record.[@b4-clep-10-1155]--[@b7-clep-10-1155] These results suggest the use of primary care records as a standalone source for research into these conditions is unsuitable and may generate bias.

In order to explore the potential for UK primary care databases to generate real world evidence (RWE) on the safety and effectiveness of antithrombotic treatment, this study investigated the extent to which secondary care bleeds are coded in primary care records among a cohort of individuals with non-valvular atrial fibrillation (NVAF). The study also sought to understand the impact of incomplete recording on estimates of bleeding risk associated with antithrombotic treatment.

Methods
=======

Data source
-----------

The study was carried out using a linked Clinical Practice Research Datalink (CPRD) -- Hospital Episode Statistics (HES) dataset. This dataset combines anonymized medical-record data for patients registered with participating GPs in England (the CPRD dataset) with details of their admissions to NHS hospitals (the HES dataset). The linked dataset therefore includes longitudinal information on diagnoses, symptoms, laboratory tests and prescriptions issued by the GP in addition to information on referrals to specialists, hospital admission diagnoses, hospital procedures and deaths.[@b8-clep-10-1155] Clinical events in the CPRD are recorded using the "Read code" clinical coding system. Hospital discharge diagnoses in HES are recorded using the international classification of disease (ICD)--10 clinical coding system. Greater than 98% of the UK population are registered with a GP and individuals registered with a GP must opt out of data collection in order to be excluded from the CPRD dataset. Despite over-representing certain geographical areas of the UK, the CPRD has been found to be representative of the UK population with regard to sex, age and ethnicity.[@b8-clep-10-1155] HES captures information on all NHS hospital admissions occurring in England and on admissions to independent sector providers if funded by the NHS (est. 98--99% of hospital activity).[@b9-clep-10-1155]

Recording of secondary care bleeds in primary care data
-------------------------------------------------------

The study population consisted of all adults with a diagnosis of atrial fibrillation recorded in the CPRD or HES who had at least one clinically relevant bleed recorded in either data source between first January 2003 and 31 January 2016 while receiving prescriptions for oral anticoagulant (OAC) treatment. Individuals with codes indicating their atrial fibrillation was valvular were excluded as despite sharing the same electrophysiological abnormality, the differing etiology of this valvular atrial fibrillation warrants the separate consideration of such individuals. Code lists defining atrial fibrillation, valvular conditions and clinically relevant bleeds are provided in the data supplement ([Tables 1](#t1-clep-10-1155){ref-type="table"}[](#t2-clep-10-1155){ref-type="table"}[](#t3-clep-10-1155){ref-type="table"}[](#t4-clep-10-1155){ref-type="table"}[](#t5-clep-10-1155){ref-type="table"}--[6](#t6-clep-10-1155){ref-type="table"}).

Within this population, all clinically relevant bleeding events recorded in the HES and the CPRD were identified using relevant diagnostic codes and classified according to the location in the body in which they occurred ([Tables 5](#t5-clep-10-1155){ref-type="table"} and [6](#t6-clep-10-1155){ref-type="table"}). We refer to "clinically relevant bleeds" to distinguish these from minor bleeds which are non-clinically consequential; such bleeds are not captured by our data source. The proportion of bleeds recorded in HES that had a corresponding record in the CPRD in the subsequent 12 weeks was calculated, overall and stratified by bleed location.

To identify factors associated with a HES bleed having a corresponding bleeding record coded in the CPRD in the subsequent 12 weeks, generalized estimating equations (GEE) binary regression analysis was performed. The GEE analysis used a binomial distribution, a logit-link and an exchangeable correlation structure to account for the inclusion of repeat bleeds per individual. Bleed characteristics considered in the analysis included OAC treatment at the time of the bleed, bleed type, calendar period, period of week of bleed occurrence (weekday vs weekend). A range of patient characteristics were also considered for inclusion in the model, including age, sex, deprivation (English Index of Multiple Deprivation),[@b10-clep-10-1155] body mass index (BMI), stroke risk factors (history of stroke/TIA, systemic thromboembolism, congestive heart failure, vascular disease, hypertension, diabetes, CHA2DS2-VASc score), bleeding risk factors (bleeding history, liver disease, renal disease, modified HAS-BLED score) and concomitant medical treatment.

Impact of recording completeness on comparative safety of antithrombotic treatment
----------------------------------------------------------------------------------

In order to further explore the impact under-recording of HES bleeds in primary care data can have on comparative safety and effectiveness analyses, a comparative safety analysis was carried out using two different data sources: a linked CPRD-HES data (linked analysis) and a CPRD only dataset (unlinked analysis). The analysis investigated the impact of using the different data sources on the relative hazard of subsequent bleeding across antithrombotic treatment strategies, within a population of individuals who had suffered a first bleed while using OACs.

For this analysis, the study population consisted of adults with a diagnosis of atrial fibrillation recorded in the CPRD or HES who had a clinically relevant bleed (index bleed) recorded in either data source between 1 January 2003 and 15 March 2012 which occurred while receiving prescriptions for an OAC. Patients were followed from index bleed until the earliest of either 15 March 2012, the date of leaving the database, or the date of death. Prescriptions for vitamin K antagonists (VKAs) or antiplatelet agents (APAs) issued following the first bleed were identified and used to stratify each individuals' follow-up time into one of three antithrombotic treatment groups: VKA treatment, APA treatment, no antithrombotic treatment. Gaps in treatment of up to 60 days between two prescriptions from the same treatment group were considered to constitute continuous treatment. Cox proportional hazard regression models were used to compare the hazard of subsequent bleeding events across treatment groups in each population, including treatment group as a time varying covariate and controlling for the same patient and bleed characteristics outlined for the GEE analysis above. Hazard ratios are reported along with Wald 95% confidence intervals.

All analyses were carried out in \[SAS/STAT\] software (SAS Institute Inc., Cary, NC, USA).

Results
=======

A total of 14,361 bleeds recorded in HES were identified among patients with NVAF receiving OAC treatment between 2003 and 2016. The proportion of HES bleeds with a corresponding bleed recorded in the CPRD increased from 12.5% in the first week following the HES bleed to 19.6% after 12 weeks ([Table 7](#t7-clep-10-1155){ref-type="table"}). Similar results, stratified by the location of the bleed, are provided in [Table 8](#t8-clep-10-1155){ref-type="table"}. A greater proportion of respiratory, intraarticular and intracranial bleeds had a consistent bleed code recorded in the CPRD within 12 weeks (30.1%, 40.7% and 39.2%, respectively) compared to bleeds in other locations, including GI bleeds (13.5%) and intraspinal bleeds (11.6%).

Patient characteristics in the linked and unlinked datasets are shown in [Table 9](#t9-clep-10-1155){ref-type="table"}. The results of the GEE regression model are provided in [Table 10](#t10-clep-10-1155){ref-type="table"}. Of the 14,361 bleeds recorded in HES, intracranial bleeds, bleeds resulting in weekend hospital admission, bleeds occurring longer ago, bleeds occurring during OAC treatment and bleeds occurring in individuals without a history of bleeding risk factors were more likely to have a corresponding bleed recorded in the CPRD in the 12 weeks after hospital admission.

After applying inclusion and exclusion criteria, 5,197 individuals were identified for inclusion in the Cox regression analyses using CPRD data only ([Figure S1](#SD1-clep-10-1155){ref-type="supplementary-material"}) and 7,063 individuals were identified for inclusion in the analysis using CPRD-HES linked data ([Figure S2](#SD2-clep-10-1155){ref-type="supplementary-material"}). On average, the population identified using linked CPRD-HES data was slightly older than the population identified using unlinked data only, and contained a greater proportion of females, individuals more recently diagnosed with NVAF, individuals with a history of stroke and bleeding risk factors and individuals with evidence of active cancer ([Table 9](#t9-clep-10-1155){ref-type="table"}). The index bleeds identified in the linked population occurred more recently and were more severe than those in the unlinked population, with a greater proportion of gastrointestinal and intracranial bleeds identified ([Table 9](#t9-clep-10-1155){ref-type="table"}).

[Figure 1](#f1-clep-10-1155){ref-type="fig"} shows the cumulative incidence of bleeding in the unlinked primary care data and the linked primary and secondary care dataset. Adjusting for statistically significant differences in the above characteristics across treatment groups within each population, we found that the hazard of subsequent bleeding associated with VKAs and APAs relative to no antithrombotic treatment were 12% and 6% higher, respectively, when using the unlinked primary care data (VKA HR~adj\ 1.12~ CI~95~ 1.01--1.24; APA HR~adj\ 1.06~ CI~95~ 0.95--1.20) and were 6% and 8% higher, respectively, when using the linked primary and secondary care dataset (VKA HR~adj\ 1.06~ CI~95~ 0.96--1.16; APA HR~adj\ 1.08~ CI~95~ 0.96--1.21).

Discussion
==========

This study found that the coding of hospital bleeds in the primary care record was incomplete, with less than 20% of individuals with an inpatient diagnosis for a bleed having a bleed coded in their primary care record in the subsequent 12 weeks. Moreover, differences with respect to key clinical and demographic characteristics were observed between patients identified from primary care vs linked data. While under-recording was found to be differential with regard to a number of factors, including OAC treatment, the incomplete recording of bleeds in primary care was not found to considerably bias estimates of the risk of bleeding associated with antithrombotic treatment.

The low proportion of secondary care bleeds having a corresponding bleed recorded in primary care indicates that as much as 80% of such bleeds could be excluded from a study which utilized primary care data only to identify bleeds. Using primary care data alone will therefore result in false-negative misclassification of exposure, outcome and/or covariate status. The impact of such misclassification is unpredictable and dependent on the study question. While our stratified and GEE analyses suggest that incompleteness varies by a range of factors including OAC treatment, calendar time and bleed location/type, our comparative safety analyses investigating the risk of subsequent bleeding associated with antithrombotic treatment illustrates that for certain study questions the impact on estimates of comparative safety or effectiveness may be small. Despite this, given the extent of under-recording and observed differences in patient characteristics, potential bias introduced through differential misclassification by these and other factors should be taken into consideration in interpreting the results of studies which have used primary care data only to identify bleeds[@b11-clep-10-1155],[@b12-clep-10-1155] and in the planning of future studies.

Of GP practices contributing to the CPRD, 57% are eligible for linkage with HES, and no individuals registered with Scottish, Welsh or Northern Irish practices are eligible.[@b13-clep-10-1155] As a result, the use of a HES linked CPRD dataset can have a considerable impact on the generalizability and sample size available for a given study. Given our observation that the impact of under-recording on relative measures of safety or effectiveness can be limited, the decision to use unlinked CPRD vs HES-linked CPRD data must be made on a study specific basis, based on a comparison of the anticipated value that the HES data can add against the reduction in sample size and generalizability it enforces. Based on the extent of under-recording of secondary care bleeding events in primary care data reported here, and the finding that the HR of subsequent bleeding for VKAs compared to no antithrombotic treatment was slightly higher when using unlinked CPRD data, we suggest that for studies in which bleeding is a key variable, HES linked data is used; at a minimum, to illustrate that findings in the HES-linked data are similar to those in the unlinked data.

Our finding that the odds of a HES bleed having a corresponding CPRD bleed has decreased over time ([Table 10](#t10-clep-10-1155){ref-type="table"}) is notable as it suggests that the quality of recording in primary care datasets has decreased over time. This is an interesting finding as it suggests recent efforts to improve and standardize the communication of discharge details between secondary and primary care (eDischarge summaries,[@b2-clep-10-1155] have yet to make an impact. There is a possibility that the decrease in recording over time may represent a change in recording practices rather than a decrease in the quality of recording, as we used specific Read codes related to a bleed in the CPRD to assess consistency with HES data; however, there may have been other Read codes recorded that suggest a bleed occurred (eg, a code for a medical condition for which bleeding is a common symptom). A previous study investigating recording of upper gastrointestinal bleeds in the CPRD and HES included a range of "probable" and "possible" bleed Read codes and found supporting evidence for a much higher percentage of HES bleeds in the CPRD (66%).[@b5-clep-10-1155] Further, in clinical practice, some Read codes may have "free text" information recorded against them confirming a bleed occurred. These "free text" data consist of unstandardized text which can be used to elaborate on the information contained in the Read code. Free text data are not currently made available for research purposes; however, they are available to individuals involved in the clinical care of patients. While the information contained in related Read codes and the free text may therefore confirm bleeds in some of the cases we have identified, given the magnitude of uncoded secondary care events it is likely that a clinically relevant proportion of individuals did not have their bleed recorded anywhere in their primary care record. These findings are in line with those of a number of studies that have identified shortcomings in communication during transition of care between secondary and primary care and which have highlighted the safety issues that may result from them.[@b14-clep-10-1155]--[@b21-clep-10-1155] From a research perspective, the unavailability of free text and non-specificity of the "possible" and "probable" codes included by Crooks et al[@b5-clep-10-1155] mean that neither represent feasible approaches to identifying bleeding events in stand-alone primary care data and the high proportions of unreported data we report remain relevant.

The observation that the odds of a HES bleed having a corresponding CPRD bleed is higher for bleeds admitted at the weekend is of interest given the publicity surrounding so-called "weekend effects" in the UK, whereby individuals admitted to hospital at the weekend are more likely to have poor outcomes. It may be possible that admission for bleeds at weekends are more likely to be recorded in the CPRD due to their association with poorer outcomes and therefore being more clinically relevant. Previous methodological work exploring the accuracy of HES data for exploring weekend effects has found that events recorded in HES data on weekdays are more likely to be prevalent events inappropriately recorded as incident events and that this may partly explain the better outcomes observed following these events.[@b22-clep-10-1155] Our finding that HES bleeds admitted on weekdays are less likely to have a corresponding bleed record in the CPRD may therefore reflect the fact that a greater proportion of the weekday admissions are not being recorded by GPs as they are not truly incident bleeds.

Beyond the weekend effect, the potential for inaccurate recording of incident events in HES is an important consideration in interpreting our findings, as thus far we have considered HES to represent a "gold standard" for recording of secondary care events and any events not recorded in the CPRD to represent under-recording in primary care. Inaccuracy in HES coding has been reported previously for a number of event types; however, since the Payment by Results system was introduced in 2004 the average accuracy of coding has been reported to be 96.0% (interquartile range: 89.3--96.2%), *P*=0.020).[@b23-clep-10-1155] Notably, this figure has been derived across a range of types of event and most of the studies contributing to this figure focused on the accuracy of ICD coding at the four digit ICD code level. This latter point is important as most of the bleeding ICD codes we have investigated would still have been captured as bleeds had they been miscoded at the four digit level but not at the three digit level. While some of the 80% of secondary care events not coded in the CPRD may therefore not have been true incident bleeds, we believe it is unlikely that a substantial proportion were. An additional limitation of our study is that it explores only the sensitivity of recording in primary care, but does not explore the specificity. In utilizing the CPRD to investigate bleeding events it is important that the potential for false positive classification of bleeds is given consideration.

A further limitation is that our descriptive analyses do not account for extended hospital stays and deaths. That is, 9% of individuals were not discharged from hospital within the 12 weeks following their index bleed. Such individuals may therefore have supporting evidence recorded later, upon discharge from hospital. Removing undischarged individuals from the denominator has a minimal impact on results, increasing the proportion with supporting evidence recorded to 21.5%. Among the 14,361 individuals with an index bleed, 16% died during the 12 week follow-up. While individuals who died during the 12 week follow-up do not have the same opportunity to have supporting evidence recorded, this is still notable from a methodological point of view as a study using primary care data may not capture bleeds presenting in secondary care and resulting in deaths within 12 weeks.

Conclusion
==========

Our results add to the evidence base suggesting secondary care events are not completely recorded in primary care records, and further that under-recording of bleeding events is differential with respect to a variety of factors, including treatment. While the impacts of under-recording on estimates of the comparative safety of antithrombotic drugs obtained from stand-alone primary care data were small, the extent of the under-recording suggests its potential impact should be considered, and ideally evaluated in future studies utilizing stand-alone primary care data.

Supplementary material
======================

###### 

Derivation of the study population for the Cox proportional hazards regression analysis using CPRD data only. Percentages shown use the total number of individuals at the next highest level in the flow as their denominator.

**Abbreviations:** CPRD, Clinical Practice Research Database; HES, hospital episode statistics; OAC, oral anticoagulant; Rx, prescription; Dx, diagnosis.

###### 

Derivation of the study population for the Cox proportional hazards regression analysis using linked CPRD-HES data. Percentages shown use the total number of individuals at the next highest level in the flow as their denominator.

**Abbreviations:** CPRD, Clinical Practice Research Database; HES, hospital episode statistics; OAC, oral anticoagulant; Rx, prescription; Dx, diagnosis.
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###### 

ICD codes used to identify individuals with atrial fibrillation

  ICD10_code   Diagnosis
  ------------ -----------------------------------------------------
  I48          Atrial fibrillation and flutter
  I48.0        Paroxysmal atrial fibrillation
  I48.1        Persistent atrial fibrillation
  I48.2        Chronic atrial fibrillation
  I48.3        Typical atrial flutter
  I48.4        Atypical atrial flutter
  I48.9        Atrial fibrillation and atrial flutter, unspecified

###### 

ICD codes used to identify and exclude individuals whose atrial fibrillation was valvular in nature

  ICD10_code   Diagnosis
  ------------ -----------------------------------------------------------------------------------------------
  I05          Rheumatic mitral valve diseases
  I05.0        Rheumatic mitral stenosis
  I05.2        Rheumatic mitral stenosis with insufficiency
  I05.8        Other rheumatic mitral valve diseases
  I05.9        Rheumatic mitral valve disease, unspecified
  I08          Multiple valve diseases
  I08.0        Disorders of both mitral and aortic valves
  I08.1        Disorders of both mitral and tricuspid valves
  I08.3        Combined disorders of mitral, aortic and tricuspid valves
  I08.8        Other multiple valve diseases
  I08.9        Multiple valve disease, unspecified
  T82.0        Mechanical complication of heart valve prosthesis
  T82.6        Infection and inflammatory reaction due to cardiacvalve prosthesis
  T82.8        Other specified complications of cardiac and vascular prosthetic devices, implants and grafts
  T82.9        Unspecified complication of cardiac and vascular prosthetic device, implant and graft
  Z95.2        Presence of prosthetic heart valve
  Z95.4        Presence of other heart-valve replacement

###### 

Read codes used to identify individuals with atrial fibrillation

  Read code   Read term
  ----------- -----------------------------------------------------------------------------------------
  14AN.00     H/O: atrial fibrillation
  14AR.00     History of atrial flutter
  3272.00     ECG: atrial fibrillation
  3273.00     ECG: atrial flutter
  662S.00     Atrial fibrillation monitoring
  6A9..00     Atrial fibrillation annual review
  7,936A00    Implant intravenous pacemaker for atrial fibrillation
  793M100     Percutaneous transluminal ablation of atrial wall for atrial flutter
  793M200     Percutaneous transluminal internal cardioversion NEC
  793M300     Percutaneous transluminal ablation of conducting system of heart for atrial flutter NEC
  8CMW200     Atrial fibrillation care pathway
  8HTy.00     Referral to atrial fibrillation clinic
  8OAD.00     Provision of written information about atrial fibrillation
  9hF..00     Exception reporting: atrial fibrillation quality indicators
  9hF1.00     Excepted from atrial fibrillation quality indicators: informed dissent
  9Os..00     Atrial fibrillation monitoring administration
  9Os0.00     Atrial fibrillation monitoring first letter
  9Os1.00     Atrial fibrillation monitoring second letter
  9Os2.00     Atrial fibrillation monitoring third letter
  9Os3.00     Atrial fibrillation monitoring verbal invite
  9Os4.00     Atrial fibrillation monitoring telephone invite
  G573.00     Atrial fibrillation and flutter
  G573000     Atrial fibrillation
  G573100     Atrial flutter
  G573200     Paroxysmal atrial fibrillation
  G573300     Non-rheumatic atrial fibrillation
  G573400     Permanent atrial fibrillation
  G573500     Persistent atrial fibrillation
  G573600     Paroxysmal atrial flutter
  G573z00     Atrial fibrillation and flutter NOS

**Abbreviations:** ECG, electrocardiogram; NEC, not elsewhere classified; H/O, history of; NOS, not otherwise specified.

###### 

Read codes used to identify and exclude individuals whose atrial fibrillation was valvular in nature

  Read code   Read term
  ----------- ------------------------------------------------------------
  7910200     Prosthetic replacement of mitral valve
  7910211     Bjork--Shiley prosthetic replacement of mitral valve
  7910212     Bjork--Shiley prosthetic replacement of mitral valve
  7910213     Carpentier prosthetic replacement of mitral valve
  7910214     Edwards prosthetic replacement of mitral valve
  7910300     Replacement of mitral valve NEC
  7910400     Mitral valvuloplasty NEC
  7911200     Prosthetic replacement of aortic valve
  7911300     Replacement of aortic valve NEC
  7911500     Transapical aortic valve implantation
  7911600     Transluminal aortic valve implantation
  7914200     Prosthetic replacement of valve of heart NEC
  7914211     Edwards prosthetic replacement of valve of heart
  7914212     Starr prosthetic replacement of valve of heart
  7914300     Replacement of valve of heart NEC
  7914600     Replacement of truncal valve
  7915000     Revision of plastic repair of mitral valve
  7916000     Open mitral valvotomy
  7917000     Closed mitral valvotomy
  7919000     Percutaneous transluminal mitral valvotomy
  7910.00     Plastic repair of mitral valve
  7910.11     Mitral valvuloplasty
  7910.12     Replacement of mitral valve
  7910y00     Other specified plastic repair of mitral valve
  7910z00     Plastic repair of mitral valve NOS
  7911.12     Replacement of aortic valve
  7914.11     Replacement of unspecified valve of heart
  G11..00     Mitral valve diseases
  G110.00     Mitral stenosis
  G112.00     Mitral stenosis with insufficiency
  G112.12     Mitral stenosis with incompetence
  G112.13     Mitral stenosis with regurgitation
  G113.00     Nonrheumatic mitral valve stenosis
  G11z.00     Mitral valve disease NOS
  G13..00     Diseases of mitral and aortic valves
  G130.00     Mitral and aortic stenosis
  G131.00     Mitral stenosis and aortic insufficiency
  G131.13     Mitral stenosis and aortic incompetence
  G131.14     Mitral stenosis and aortic regurgitation
  G13y.00     Multiple mitral and aortic valve involvement
  G13z.00     Mitral and aortic valve disease NOS
  G540z00     Mitral valve disorders NOS
  G544.00     Multiple valve diseases
  G544100     Disorders of both mitral and tricuspid valves
  G544200     Combined disorders of mitral, aortic and tricuspid valves
  G544X00     Multiple valve disease, unspecified
  Gyu1000     \[X\]Other mitral valve diseases
  Gyu5500     \[X\]Other nonrheumatic mitral valve disorders
  Gyu5D00     \[X\]Multiple valve disorders/diseases CE
  P65..00     Congenital mitral stenosis
  P650.00     Congenital mitral stenosis, unspecified
  P65z.00     Congenital mitral stenosis NOS
  SP00200     Mechanical complication of heart valve prosthesis
  SyuK611     \[X\]Embolism from prosthetic heart valve
  TB01200     Implant of heart valve prosthesis + complication, no blame
  ZV43300     \[V\]Has artificial heart valve
  ZV45H00     \[V\]Presence of prosthetic heart valve
  ZVu6e00     \[X\]Presence of other heart valve replacement

**Notes:** \[V\] Supplementary factors influencing health status or contact with health services other than for illness (ICD). \[X\] Terms which have been added to the Read Codes in order to ensure that every ICD-10 code is cross-mapped to from a Read Code.

**Abbreviations:** NEC, not elsewhere classified; NOS, not otherwise specified.

###### 

ICD codes defining clinically relevant hospital bleeds and their locations

  ICD code   Description                                                                                                              Location
  ---------- ------------------------------------------------------------------------------------------------------------------------ ----------
  I85.0      Esophageal varices with bleeding                                                                                         GI
  K25.0      Gastric ulcer, acute with hemorrhage                                                                                     GI
  K25.2      Gastric ulcer, acute with both hemorrhage and perforation                                                                GI
  K25.4      Gastric ulcer, chronic or unspecified with hemorrhage                                                                    GI
  K25.6      Chronic or unspecified with both hemorrhage and perforation                                                              GI
  K26.0      Duodenal ulcer, acute with hemorrhage                                                                                    GI
  K26.2      Duodenal ulcer, acute with both hemorrhage and perforation                                                               GI
  K26.4      Duodenal ulcer, chronic or unspecified with hemorrhage                                                                   GI
  K26.6      Chronic or unspecified with both hemorrhage and perforation                                                              GI
  K27.0      Peptic ulcer, acute with hemorrhage                                                                                      GI
  K27.2      Peptic ulcer, acute with both hemorrhage and perforation                                                                 GI
  K27.4      Peptic ulcer, chronic or unspecified with hemorrhage                                                                     GI
  K27.6      Chronic or unspecified with both hemorrhage and perforation                                                              GI
  K28.0      Gastrojejunal ulcer, acute with hemorrhage                                                                               GI
  K28.2      Acute with both hemorrhage and perforation                                                                               GI
  K28.4      Gastrojejunal ulcer, chronic or unspecified with hemorrhage                                                              GI
  K28.6      Chronic or unspecified with both hemorrhage and perforation                                                              GI
  K29.0      Acute hemorrhagic gastritis                                                                                              GI
  K62.5      Hemorrhage of anus and rectum                                                                                            GI
  K92.0      Hematemesis                                                                                                              GI
  K92.1      Melena                                                                                                                   GI
  K92.2      Gastrointestinal hemorrhage, unspecified                                                                                 GI
  I84.1      Internal hemorrhoids with other complications                                                                            GI
  I84.3      External thrombosed hemorrhoids                                                                                          GI
  I84.4      External hemorrhoids with other complications                                                                            GI
  I84.8      Unspecified hemorrhoids with other complications                                                                         GI
  I98.3      Esophageal varices with bleeding in diseases classified elsewhere                                                        GI
  K22.6      Gastro-esophageal laceration-hemorrhage syndrome                                                                         GI
  K31.8      Angiodysplasia of stomach and duodenum with hemorrhage                                                                   GI
  K55.2      Angiodysplasia of the colon with bleeding                                                                                GI
  K55.8      Angiodysplasia of the small intestine with hemorrhage                                                                    GI
  K57.0      Diverticulosis of the small intestine with perforation, abscess and bleeding                                             GI
  K57.1      Diverticulosis of the small intestine without perforation and abscess, with bleeding                                     GI
  K57.2      Diverticulosis of the colon with perforation, abscess and bleeding                                                       GI
  K57.3      Diverticulosis of the colon without perforation or abscess, with bleeding                                                GI
  K57.4      Diverticular disease of both the small intestine and the large intestine with perforation, abscess and bleeding          GI
  K57.5      Diverticular disease of both the small intestine and the large intestine without perforation or abscess, with bleeding   GI
  K57.8      Diverticular disease of intestine, part unspecified, with perforation, abscess and bleeding                              GI
  K57.9      Diverticular disease of intestine, part unspecified, without perforation or abscess, with bleeding                       GI
  I60        Subarachnoid hemorrhage                                                                                                  IC
  I60.0      Subarachnoid hemorrhage from carotid siphon and bifurcation                                                              IC
  I60.1      Subarachnoid hemorrhage from middle cerebral artery                                                                      IC
  I60.2      Subarachnoid hemorrhage from anterior communicating artery                                                               IC
  I60.3      Subarachnoid hemorrhage from posterior communicating artery                                                              IC
  I60.4      Subarachnoid hemorrhage from basilar artery                                                                              IC
  I60.5      Subarachnoid hemorrhage from vertebral artery                                                                            IC
  I60.6      Subarachnoid hemorrhage from other intracranial arteries                                                                 IC
  I60.7      Subarachnoid hemorrhage from intracranial artery, unspecified                                                            IC
  I60.8      Other subarachnoid hemorrhage                                                                                            IC
  I60.9      Subarachnoid hemorrhage, unspecified                                                                                     IC
  I61        Intracerebral hemorrhage                                                                                                 IC
  I61.0      Intracerebral hemorrhage in hemisphere, subcortical                                                                      IC
  I61.1      Intracerebral hemorrhage in hemisphere, cortical                                                                         IC
  I61.2      Intracerebral hemorrhage in hemisphere, unspecified                                                                      IC
  I61.3      Intracerebral hemorrhage in brain stem                                                                                   IC
  I61.4      Intracerebral hemorrhage in cerebellum                                                                                   IC
  I61.5      Intracerebral hemorrhage, intraventricular                                                                               IC
  I61.6      Intracerebral hemorrhage, multiple localized                                                                             IC
  I61.8      Other intracerebral hemorrhage                                                                                           IC
  I61.9      Intracerebral hemorrhage, unspecified                                                                                    IC
  I62        Other nontraumatic intracranial hemorrhage                                                                               IC
  I62.0      Subdural hemorrhage (acute) (nontraumatic)                                                                               IC
  I62.1      Nontraumatic extradural hemorrhage                                                                                       IC
  I62.9      Intracranial hemorrhage (nontraumatic), unspecified                                                                      IC
  I69.0      Sequelae of subarachnoid hemorrhage                                                                                      IC
  I69.1      Sequelae of intracerebral hemorrhage                                                                                     IC
  I69.2      Sequelae of other nontraumatic intracranial hemorrhage                                                                   IC
  S06.5      Traumatic subdural hemorrhage                                                                                            IC
  S06.6      Traumatic subarachnoid hemorrhage                                                                                        IC
  S06.4      Epidural hemorrhage                                                                                                      IS
  G95.1      Vascular myelopathies (including hematomyelia)                                                                           IS
  H21.0      Hyphema                                                                                                                  IO
  H31.41     Hemorrhagic choroidal detachment                                                                                         IO
  H35.73     Hemorrhagic detachment of retinal pigment epithelium                                                                     IO
  H44.81     Hemophthalmos                                                                                                            IO
  H47.02     Hemorrhage in optic nerve sheath                                                                                         IO
  H31.3      Choroidal hemorrhage and rupture                                                                                         IO
  H35.6      Retinal hemorrhage                                                                                                       IO
  H43.1      Vitreous hemorrhage                                                                                                      IO
  H45.0      Vitreous hemorrhage in diseases classified elsewhere                                                                     IO
  N42.1      Congestion and hemorrhage of prostate                                                                                    U
  N02        Recurrent and persistent hematuria                                                                                       U
  N02.6      Recurrent and persistent hematuria, dense deposit disease                                                                U
  N02.8      Recurrent and persistent hematuria, other                                                                                U
  N02.9      Recurrent and persistent hematuria, unspecified                                                                          U
  R31        Unspecified hematuria                                                                                                    U
  R31.0      Gross hematuria                                                                                                          U
  R31.9      Hematuria, unspecified                                                                                                   U
  M25.0      Hemarthrosis                                                                                                             IA
  R04        Hemorrhage from respiratory passages                                                                                     R
  R04.1      Hemorrhage from throat                                                                                                   R
  J94.2      Hemothorax                                                                                                               R
  R04.0      Epistaxis                                                                                                                R
  R04.2      Hemoptysis                                                                                                               R
  R04.8      Hemorrhage from other sites in respiratory passages                                                                      R
  R04.9      Hemorrhage from respiratory passages, unspecified                                                                        R
  I23.0      Hemopericardium as current complication following acute myocardial infarction                                            PC
  I31.2      Hemopericardium, not elsewhere classified                                                                                PC
  S26.0      Injury of heart with hemopericardium                                                                                     PC
  N83.6      Hematosalpinx                                                                                                            GYN
  N85.7      Hematometra                                                                                                              GYN
  N89.7      Hematocolpos                                                                                                             GYN
  N92.1      Excessive and frequent menstruation with irregular cycle                                                                 GYN
  N93        Other abnormal uterine and vaginal bleeding                                                                              GYN
  N93.8      Other specified abnormal uterine and vaginal bleeding                                                                    GYN
  N93.9      Abnormal uterine and vaginal bleeding, unspecified                                                                       GYN
  N95.0      Postmenopausal bleeding                                                                                                  GYN
  D69        Purpura and other hemorrhagic conditions                                                                                 CUT
  I71.3      Abdominal aortic aneurysm, ruptured                                                                                      RP
  I71.5      Thoracoabdominal aortic aneurysm, ruptured                                                                               RP
  K66.1      Hemoperitoneum                                                                                                           RP
  H11.3      Conjunctival hemorrhage                                                                                                  OTH
  R31.1      Benign essential microscopic hematuria                                                                                   OTH
  H92.2      Otorrhagia                                                                                                               OTH
  I71.1      Thoracic aortic aneurysm, ruptured                                                                                       OTH
  I71.8      Aortic aneurysm of unspecified site, ruptured                                                                            OTH
  E07.8      Other specified disorders of thyroid (including hemorrhage of thyroid)                                                   OTH
  E27.4      Other and unspecified adrenocortical insufficiency (including adrenal hemorrhage)                                        OTH
  M62.2      Ischemic infarction of muscle (compartment syndrome, non-traumatic)                                                      COMP
  T79.6      Traumatic ischemia of muscle (compartment syndrome)                                                                      COMP

**Abbreviations:** IC, intracranial bleed; GI, gastrointestinal bleed; IS, intraspinal bleed; IO, intraocular bleed; PC, pericardial bleed; U, urinary bleed; IA, intraarticular bleed; R, respiratory; GYN, gynecological bleed; COMP, compartment syndrome; CUT, cutaneous/subcutaneous hemorrhage; RP, retroperitoneal bleed; OTH, other bleed.

###### 

Read codes identifying bleeds in the CPRD

  Readcode     Description                                                    Location
  ------------ -------------------------------------------------------------- ----------
  158..12      Vaginal bleeding                                               GYN
  16R..00      Bleeding symptom                                               OTH
  1928.00      Bleeding gums                                                  GUM
  196B.00      Painful rectal bleeding                                        GI
  196C.00      Painless rectal bleeding                                       GI
  1C6..00      Nose bleed symptom                                             R
  1C62.00      Has nose bleeds - epistaxis                                    R
  1C6Z.00      Nose bleed symptom NOS                                         R
  2BB5.00      O/E - retinal haemorrhages                                     IO
  2BB8.00      O/E - vitreous haemorrhages                                    IO
  7017000.00   Evacuation of subdural haematoma                               IC
  7404.00      Surgical arrest of bleeding from internal nose                 R
  F42y.11      Haemorrhage - retinal                                          IO
  F42y400      Subretinal haemorrhage                                         IO
  F42y500      Retinal haemorrhage NOS                                        IO
  F444000      Hyphaema                                                       IO
  F4K2800      Vitreous haemorrhage                                           IO
  G60..00      Subarachnoid haemorrhage                                       IC
  G61..00      Intracerebral haemorrhage                                      IC
  G61..11      CVA - cerebrovascular accid due to intracerebral haemorrhage   IC
  G61..12      Stroke due to intracerebral haemorrhage                        IC
  G610.00      Cortical haemorrhage                                           IC
  G612.00      Basal nucleus haemorrhage                                      IC
  G613.00      Cerebellar haemorrhage                                         IC
  G617.00      Intracerebral haemorrhage, intraventricular                    IC
  G61X000      Left sided intracerebral haemorrhage, unspecified              IC
  G61X100      Right sided intracerebral haemorrhage, unspecified             IC
  G61z.00      Intracerebral haemorrhage NOS                                  IC
  G62..00      Other and unspecified intracranial haemorrhage                 IC
  G620.00      Extradural haemorrhage - nontraumatic                          IC
  G621.00      Subdural haemorrhage - nontraumatic                            IC
  G622.00      Subdural haematoma - nontraumatic                              IC
  G623.00      Subdural haemorrhage NOS                                       IC
  G62z.00      Intracranial haemorrhage NOS                                   IC
  G850.00      Oesophageal varices with bleeding                              GI
  G8y0.00      Haemorrhage NOS                                                OTH
  Gyu6200      \[X\]Other intracerebral haemorrhage                           IC
  J110100      Acute gastric ulcer with haemorrhage                           GI
  J110111      Bleeding acute gastric ulcer                                   GI
  J121100      Chronic duodenal ulcer with haemorrhage                        GI
  J121111      Bleeding chronic duodenal ulcer                                GI
  J130100      Acute peptic ulcer with haemorrhage                            GI
  J150000      Acute haemorrhagic gastritis                                   GI
  J510900      Bleeding diverticulosis                                        GI
  J573.00      Haemorrhage of rectum and anus                                 GI
  J573.11      Bleeding PR                                                    GI
  J573000      Rectal haemorrhage                                             GI
  J573011      Rectal bleeding                                                GI
  J573012      PRB - Rectal bleeding                                          GI
  J68..00      Gastrointestinal haemorrhage                                   GI
  J681.00      Melaena                                                        GI
  J68z.00      Gastrointestinal haemorrhage unspecified                       GI
  J68z.11      GIB - Gastrointestinal bleeding                                GI
  J68z000      Gastric haemorrhage NOS                                        GI
  J68z100      Intestinal haemorrhage NOS                                     GI
  J68z200      Upper gastrointestinal haemorrhage                             GI
  J68zz00      Gastrointestinal tract haemorrhage NOS                         GI
  K0A2.00      Recurrent and persistent haematuria                            U
  K197.00      Haematuria                                                     U
  K197000      Painless haematuria                                            U
  K197100      Painful haematuria                                             U
  K197300      Frank haematuria                                               U
  K19y400      Bleeding from urethra                                          U
  K19y411      Urethral bleeding                                              U
  K31y000      Breast haematoma due to nontraumatic cause                     OTH
  K56y111      Bleeding - vaginal NOS                                         GYN
  K56y112      BPV - Vaginal bleeding                                         GYN
  K5E..00      Other abnormal uterine and vaginal bleeding                    GYN
  K5E2.00      Abnormal vaginal bleeding, unspecified                         GYN
  N091.00      Haemarthrosis                                                  IA
  N091611      Haemarthrosis of the knee                                      IA
  N091M00      Haemarthrosis of knee                                          IA
  N091z00      Haemarthrosis NOS                                              IA
  R047.00      \[D\]Epistaxis                                                 R
  R047.11      \[D\]Nosebleed                                                 R
  R063.00      \[D\]Haemoptysis                                               R
  R063100      \[D\]Pulmonary haemorrhage NOS                                 R
  R063z00      \[D\]Haemoptysis NOS                                           R
  S62..00      Cerebral haemorrhage following injury                          IC
  S62..11      Extradural haemorrhage following injury                        IC
  S62..13      Subdural haemorrhage following injury                          IC
  S622.00      Closed traumatic subdural haemorrhage                          IC
  S629.00      Traumatic subdural haematoma                                   IC
  S62A.00      Traumatic extradural haematoma                                 IC
  S63..00      Other cerebral haemorrhage following injury                    IC
  S780500      Retroperitoneal haematoma                                      RP
  SE\...11     Haematoma with intact skin                                     CUT
  SE46.00      Traumatic haematoma                                            OTH
  SE4z.11      Haematoma NOS                                                  OTH
  SK02.00      Secondary and recurrent haemorrhage                            OTH
  SK0y.11      Anterior compartment syndrome                                  COMP
  SK0y.12      Compartment syndrome                                           COMP
  SK0y700      Compartment syndrome                                           COMP
  SP21.00      Peri-operative haemorrhage or haematoma                        OTH
  SP21.12      Haemorrhage - postoperative                                    OTH

**Notes:** \[D\] diagnosis. \[X\] Terms which have been added to the Read Codes in order to ensure that every ICD-10 code is cross-mapped to from a Read Code.

**Abbreviations:** O/E, on examination; PRB, per-rectal bleeding; PR, per-rectum; NOS, not otherwise specified; BPV, bleeding per vagina; IC, intracranial bleed; GI, gastrointestinal bleed; IS, intraspinal bleed; IO, intraocular bleed; PC, pericardial bleed; U, urinary bleed; IA, intraarticular bleed; R, respiratory; GYN, gynecological bleed; COMP, compartment syndrome; CUT, cutaneous/subcutaneous hemorrhage; RP, retroperitoneal bleed; GUM, gum bleed; OTH, other bleed.

###### 

HES bleeds with a corresponding bleed recorded in the CPRD in the subsequent 12 weeks

  Bleeds in HES (n=14,361)   Corresponding bleed recorded in CPRD N (%)   
  -------------------------- -------------------------------------------- --------
  **Weeks after blee**d                                                   
  +1 (0--7 days)             1,799                                        (12.5)
  +2 (0--14 days)            2,110                                        (14.7)
  +4 (0--28 days)            2,372                                        (16.5)
  +6 (0--42 days)            2,543                                        (17.7)
  +8 (0--56 days)            2,653                                        (18.5)
  +10 (0--70 days)           2,748                                        (19.1)
  +12 (0--84 days)           2,822                                        (19.6)

**Abbreviations:** HES, hospital episode statistics; CPRD, Clinical Practice Research Datalink.

###### 

HES bleeds with direct, plausible or possible supporting evidence in the CPRD within 12 weeks, by location of HES bleed

  Bleeds in HES                                 Corresponding bleed recorded in CPRD N (%)   
  --------------------------------------------- -------------------------------------------- --------
  **Locatio**n                                                                               
  Total (n=14,361)                              2,822                                        (19.6)
  Intracranial bleed (n=1,713)                  620                                          (39.2)
  GI bleed (n=7,797)                            1,051                                        (13.5)
  Intraspinal bleed (n=43)                      5                                            (11.6)
  Intraocular bleed, major (n=7)                \<5                                          (NR)
  Intraocular bleed, not major (n=82)           13                                           (15.8)
  Pericardial bleed (n\<5)                      \<5                                          (NR)
  Urinary bleed (n=2,296)                       449                                          (19.6)
  Intraarticular bleed (n=162)                  66                                           (40.7)
  Respiratory bleed, major (n\<5)               \<5                                          (NR)
  Respiratory bleed, not major (n=1,984)        597                                          (30.1)
  Gynecological bleed (n\<5)                    \<5                                          (NR)
  Compartment syndrome (n=39)                   7                                            (17.9)
  Cutaneous/subcutaneous hemorrhage (n\<5)      \<5                                          (NR)
  Retroperitoneal bleed (n=84)                  \<5                                          (NR)
  Intraabdominal retroperitoneal bleed (n=41)   11                                           (26.8)
  Gum bleed (n\<5)                              \<5                                          (NR)
  Other bleed (n=107)                           \<5                                          (NR)

**Abbreviations:** HES, hospital episode statistics; CPRD, Clinical Practice Research Datalink; GI, gastrointestinal; NR, not reported.

###### 

Patient characteristics in the linked and unlinked datasets used in the Cox regression analyses

                                                                                  Linked CPRD-HES n=7,063   Unlinked CPRD n=5,197
  ------------------------------------------------------------------------------- ------------------------- -----------------------
  Age, mean (SD)                                                                  76.7 (9.5)                76.0 (9.4)
  Female, %                                                                       45.9                      42.2
  **NVAF characteristics**                                                                                  
  NVAF duration (from first AF diagnosis to index bleed)                          24.9 (24.2)               29.1 (24.1)
  NVAF duration (categorized), %                                                                            
  \<3 months, %                                                                   19.0                      8.4
  3--6 months, %                                                                  8.4                       8.0
  6--9 months, %                                                                  7.1                       7.7
  9--12 months, %                                                                 5.6                       6.6
  ≥12 months, %                                                                   59.8                      69.3
  Newly diagnosed NVAF (past 12 months), %                                        40.2                      30.7
  Duration of available baseline period (months), mean (SD)                       465 (213)                 476 (208)
  Duration of follow-up period in months, mean (SD)                               59.7 (40.7)               56.0 (35.9)
  **Index bleed characteristics**                                                                           
  Calendar year of index bleed, %                                                                           
  2003--2007                                                                      52.3                      59.0
  2008--2012                                                                      47.7                      41.0
  Site of initial bleed, %                                                                                  
  Gastrointestinal                                                                39.5                      29.6
  Respiratory                                                                     20.2                      23.6
  Urinary                                                                         20.0                      23.9
  Intracranial                                                                    7.4                       5.0
  Intraocular                                                                     1.7                       2.3
  Gynecological                                                                   1.7                       2.7
  Intraarticular                                                                  1.4                       1.5
  Gum                                                                             0.7                       1.2
  Retroperitoneal                                                                 0.5                       0
  All other bleeds                                                                7.0                       10.2
  Major bleed, %                                                                  17.2                      8.3
  **History of bleeding risk factors**                                                                      
  Bleeding history/predisposition, %                                              55.1                      42.2
  Liver disease, %                                                                1.7                       0.5
  Renal disease, %                                                                23.5                      25.6
  Drugs predisposing to bleeding[a](#tfn9-clep-10-1155){ref-type="table-fn"}, %   13.2                      18.1
  Modified HAS-BLED score (0--8), mean (SD)                                       3.0 (1.1)                 2.6 (1.2)
  Serum creatinine, mean (SD)                                                     103.7 (52.1)              104.9 (51.3)
  Glomerular filtration rate, mean (SD)                                           0.34 (0.4)                0.34 (0.3)
  **History of stroke risk factors**                                                                        
  Stroke/TIA, %                                                                   24.6                      20.4
  Systemic thromboembolism, %                                                     1.4                       0.7
  Congestive heart failure, %                                                     28.2                      21.8
  Vascular diseases, %                                                            25.2                      38.2
  Hypertension, %                                                                 90.0                      60.9
  Diabetes, %                                                                     16.4                      15.7
  CHAD2 score (0 to 6), mean (SD)                                                 2.5 (1.3)                 2.0 (1.3)
  CHA2DS2-VASc score (0--10), mean (SD)                                           4.1 (1.6)                 3.7 (1.7)
  **Other medical histories**                                                                               
  Smoking status, %                                                                                         
  Current                                                                         14.3                      15.2
  Past or never[b](#tfn10-clep-10-1155){ref-type="table-fn"}                      2.5                       2.9
  Unknown                                                                         84.2                      83.0
  BMI, mean (SD)                                                                  27.4 (5.7)                28.1 (5.8)
  Underweight, %                                                                  2.2                       1.6
  Normal, %                                                                       30.5                      20.0
  Obese, %                                                                        23.5                      21.6
  Overweight, %                                                                   35.3                      25.0
  Unknown, %                                                                      8.5                       31.8
  Weight, mean (SD)                                                               78.7 (18.4)               81.0 (19.4)
  Active cancer (current/prior 12 months), %                                      9.6                       4.9
  Falls, %                                                                        0.1                       0.2

**Notes:**

Prescriptions within 90 days prior to index bleed.

May overlap with current smoker.

**Abbreviations:** HAS-BLED, hypertension, abnormal renal and liver function, stroke, bleeding, labile INR, elderly, drugs or alcohol; HES, hospital episode statistics; CPRD, Clinical Practice Research Datalink; AF, atrial fibrillation; NVAF, non-valvular atrial fibrillation; BMI, body mass index; TIA, transient ischemic attack.

###### 

Generalized estimating equations (GEE) binary regression analysis investigating factors associated with a HES bleed being recorded in the CPRD

  Variables                                                                                                       OR     95% CI
  ------------------------------------------------------------------ -------------------------------------------- ------ --------------
  Day of week                                                        Weekday (reference)                          1      --
                                                                     Weekend                                      1.25   (1.12--1.39)
  Calendar period 2003--2005                                                                                      1.43   (1.19--1.71)
                                                                     2006--2008                                   1.31   (1.12--1.52)
                                                                     2009--2011                                   1.09   (0.93--1.26)
                                                                     2012--2016 (reference)                       1      --
  OAC treatment at time of index bleed                               No (reference)                               1      --
                                                                     Yes                                          2.26   (1.58--3.23)
  Bleed type                                                         Intracranial major (reference)               1      --
                                                                     Extracranial major                           0.39   (0.32--0.48)
                                                                     GI CRNMB leading to hospitalization          0.29   (0.24--0.35)
                                                                     GI CRNMB not leading to hospitalization      0.32   (0.24--0.43)
                                                                     Other CRNMB leading to hospitalization       0.44   (0.34--0.56)
                                                                     Other CRNMB not leading to hospitalization   0.48   (0.37--0.63)
  History of GI ulceration, GI bleeding or intracranial hemorrhage   No (reference)                               1      --
                                                                     Yes                                          0.75   (0.62--0.91)

**Notes:** Time since NVAF diagnosis also adjusted for in the analysis.

**Abbreviations:** HES, hospital episode statistics; CPRD, Clinical Practice Research Datalink; OAC, oral anticoagulant; GI, gastrointestinal; CRNMB, clinically relevant non-major bleed; NVAF, non-valvular atrial fibrillation.
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